Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 4Neoplasms 3Cardiovascular Diseases 2Urogenital Neoplasms 1Smoldering Multiple Myeloma 1Sarcoma 1Psoriasis 1Prostatic Neoplasms 1Precancerous Conditions 1Pain 1Osteoarthritis 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypertension 1Head and Neck Neoplasms 1Fatigue 1Diabetes Mellitus 1Depressive Disorder, Major 1Depression 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthralgia 1

Interventions

Nutrition Assessment 2Fatty Acids, Omega-3 2Vorinostat 1Vitamin E 1Tumor Necrosis Factor Inhibitors 1Therapeutics 1Sugars 1Rosuvastatin Calcium 1Resistance Training 1Omeprazole 1Naproxen 1Methods 1Liraglutide 1Jogging 1Geritol 1Fish Oils 1Febuxostat 1Desvenlafaxine Succinate 1Colchicine 1Cholecalciferol 1Chocolate 1Bortezomib 1Atorvastatin 1Aspirin 1Antirheumatic Agents 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Cardiovascular Diseases × Fatty Acids, Omega-3 × Clear all
NCT01169259 2025-11-06

VITAL

Brigham and Women's Hospital

Phase 3 Active not recruiting
25,871 enrolled 38 charts

Cardiovascular Diseases, Neoplasms

NCT01803711 2017-12-27

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

UConn Health

Phase 2/3 Terminated
6 enrolled 4 charts

Cardiovascular Diseases, Depression, Depressive Disorder, Major, Diabetes Mellitus, Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡